Format

Send to:

Choose Destination
See comment in PubMed Commons below
Int J Cosmet Sci. 2006 Dec;28(6):447-51. doi: 10.1111/j.1467-2494.2006.00349.x.

Evaluation of anti-wrinkle efficacy of adenosine-containing products using the FOITS technique.

Author information

  • 1L'OrĂ©al Recherche, 94152 Chevilly-Larue Cedex, France. mlabella@rd.loreal.com

Abstract

The objective of this study was to evaluate formulations containing adenosine to reduce periorbital lines and glabellar frowns in a blind, randomised, placebo-controlled study. One hundred twenty-six female volunteers between 45 and 65 years of age fulfilled inclusion criteria for periorbital lines. They were provided with two of three products (cream with adenosine, dissolvable film with adenosine or placebo), to be applied to the periorbital area on each side of the face (84 subjects per product). Eighty-four of these subjects also fulfilled the inclusion criteria for glabellar frowns, and received placebo or cream with adenosine to be applied to the glabellar area. Products were applied twice daily for 2 months, and evaluation was performed under dermatological supervision at 0, 3 and 8 weeks using Fast Optical in vivo Topometry of human Skin (FOITS) analysis to describe skin profile. Both adenosine-containing products led to significant improvements in skin smoothness in the periorbital area. Improvements were evidenced after 3 weeks of product application as measured by Ra and Rz parameters using the FOITS technique, and were steadily confirmed after 2 months, despite severe climatic conditions and independently of the analysis technique that was used with the FOITS data. Adenosine-containing cream also significantly improved glabellar frowns. This study demonstrates the potential beneficial effects of adenosine-containing products on crow's feet and glabellar facial wrinkles.

PMID:
18489289
[PubMed]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Write to the Help Desk